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Death-associated protein 5 (DAP5/p97) is a homolog
of the eukaryotic initiation factor 4G (eIF4G) that
promotes the IRES-driven translation of multiple
cellular mRNAs. Central to its function is the middle
domain (MIF4G), which recruits the RNA helicase
eIF4A. The middle domain of eIF4G consists of
tandem HEAT repeats that coalesce to form a sole-
noid-type structure. Here, we report the crystal
structure of the DAP5 MIF4G domain. Its overall
fold is very similar to that of eIF4G; however, signifi-
cant conformational variations impart distinct
surface properties that could explain the observed
differences in IRES binding between the two
proteins. Interestingly, quantitative analysis of the
DAP5-eIF4A interaction using isothermal titration
calorimetry reveals a 10-fold lower affinity than with
the eIF4G-eIF4A interaction that appears to affect
their ability to stimulate eIF4A RNA unwinding
activity in vitro. This difference in stability of the
complex may have functional implications in select-
ing the mode of translation initiation.
INTRODUCTION
Translation initiation is the rate-limiting step of protein synthesis
and involves assembly of the ribosome on themRNA followed by
recognition of the start codon. Initiation can be carried out in two
different ways: the canonical mode of translation initiation is cap-
dependent and proceeds by assembly of the eIF4F complex on
the mRNA 50 m7GpppX cap (where X is any nucleotide) structure
and subsequent formation of the preinitiation complex contain-
ing the 40S ribosomal subunit (Sonenberg and Hinnebusch,
2009). An alternative mode of translation initiation is cap-inde-
pendent and involves access of the ribosome to the mRNA via
an internal ribosomal entry site (IRES) typically found in the
50 untranslated region (50 UTR) (Holcik and Sonenberg, 2005).
The IRES recruits the ribosome directly without the need for
the mRNA cap or eIF4E.Structure 21The eIF4F complex consists of the cap-binding protein eIF4E,
the scaffolding protein eIF4G, and an ATP-dependent RNA heli-
case eIF4A, whose RNA duplex unwinding and ATP hydrolysis
activities are coupled and stimulated by eIF4B and eIF4G (O¨zesx
et al., 2011). eIF4G is a large 175 kDa protein with interaction
sites for its binding partners spread over multiple domains
(Figure 1A). There are two isoforms of eIF4G, eIF4GI and eIF4GII,
that share 46% sequence identity; in this paper, we refer to
both isoforms as ‘‘eIF4G’’ unless indicated otherwise. In addition
to recruiting eIF4E and eIF4A, eIF4G interacts with a number
of other factors required for efficient translation, including
the 40S ribosome-associated eIF3, the poly(A)-binding protein
(PABP), and the Ser/Thr kinase Mnk-1 (Pre´voˆt et al., 2003)
(Figure 1A). PABP connects eIF4F with the poly(A) tail and thus
circularizes the mRNA for increased translational efficiency.
Mnk-1 phosphorylates eIF4E, which stimulates translation (Furic
et al., 2010).
The middle domain of eIF4G, termed the MIF4G domain,
carries out a number of important functions. This segment of
approximately 30 kDa mediates protein-protein interactions
with eIF4A and eIF3 and also displays RNA and DNA binding
capabilities (Ponting, 2000). It has been shown to interact directly
with the IRES element of the encephalomyocarditis virus (EMCV)
RNA (Pestova et al., 1996; Lomakin et al., 2000) and allows eIF4G
to recruit the ribosome to the EMCV RNA in a cap-independent
manner by interacting with eIF3 and the RNA at the same time.
EMCV is a member of the picornavirus family of viruses, which
have the ability to shut down cap-dependent translation initiation
in the host. One example of such a mechanism commonly
employed by picornaviruses is proteolytic cleavage of eIF4G, re-
sulting in the separation of the eIF4E and PABP binding sites
from the rest of the protein and concomitant blockage of cap-
dependent translation (Figure 1A). This permits the virus to hijack
the translational machinery to efficiently translate its own RNA
via IRES-interacting elements in the MIF4G domain.
Cleavage of eIF4G can also occur in noninfected cells during
the process of apoptosis, where two caspase cleavage sites
in eIF4GI break it into three fragments, thereby impairing cap-
dependent translation (Bushell et al., 2000) (Figure 1A). Despite
this, it has been observed that the translation of a few spe-
cific mRNAs is maintained during apoptosis. The translation
of these mRNAs occurs via cap-independent mechanisms
that are at least to some extent modulated by the protein, 517–527, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 517
Figure 1. Domain Structure and Sequence
Alignment of DAP5 and eIF4G
(A) DAP5 and eIF4GI domain organization high-
lighting their similarities. Approximate protease
cleavage locations are indicated with arrows.
(B) Structure-based sequence alignment of MIF4G
domains of human DAP5, human eIF4GII, and
TIF4631 (S. cerevisiae eIF4G). Residues inter-
acting with eIF4A are highlighted in red. The
remainder of the sequence is colored based on
conservation using BLOSUM62 scores (Eddy,
2004). Secondary structure elements are shown
over the sequence aligned and identified using the
same color code as in Figure 2A.
Structure
Crystal Structure of the DAP5 MIF4G DomainDAP5/p97/NAT1/eIF4G2 (Henis-Korenblit et al., 2000; Lewis
et al., 2008; Nevins et al., 2003; Warnakulasuriyarachchi et al.,
2004) (DAP5 [Levy-Strumpf et al., 1997]; p97 [Imataka et al.,
1997]; NAT1 [Yamanaka et al., 1997]; eIF4G2 [Shaughnessy
et al., 1997]). In this paper, we refer to this protein using the
‘‘DAP5’’ nomenclature. DAP5 is homologous to the C-terminal
two-thirds of eIF4G and is similar in length to the fragment gener-
ated by picornaviral proteolysis (Figure 1A). It is abundantly
expressed in proliferating cells (Lee and McCormick, 2006) and
contains the important MIF4G domain as well as the MA3
domain. Consistent with its homology to eIF4G, DAP5 interacts
with eIF4A and eIF3 but not eIF4E (Imataka et al., 1997; Imataka
and Sonenberg, 1997; Yamanaka et al., 1997). However, in con-
trast to eIF4G, the MA3 domain of DAP5 does not support eIF4A
binding (Imataka and Sonenberg, 1997), leaving DAP5 with a
single interaction domain for eIF4A as compared to eIF4G’s
two binding domains.
Because of the lack of an eIF4E binding site, DAP5 is
not involved in cap-dependent translation and was reported to
be an inhibitor of translation based on overexpression studies
(Imataka et al., 1997; Yamanaka et al., 1997). Later it was
demonstrated that DAP5 mediates the IRES-driven transla-
tion of a number of cellular mRNAs. For example, during apo-
ptosis and other stress conditions, DAP5 specifically enhances518 Structure 21, 517–527, April 2, 2013 ª2013 Elsevier Ltd All rights reservedthe IRES-driven translation of several
mRNAs, including those coding for the
proteins c-IAP1/HIAP2, XIAP, Apaf-1,
c-myc, and DAP5 itself (Henis-Korenblit
et al., 2000, 2002; Hundsdoerfer et al.,
2005; Lewis et al., 2008; Nevins
et al., 2003; Warnakulasuriyarachchi
et al., 2004).
During apoptosis, DAP5 is cleaved
close to the C terminus near its Mnk-1
binding site, generating an 86 kDa frag-
ment that is more active (Figure 1A)
(Henis-Korenblit et al., 2000). In addition
to its role in apoptosis and stress, DAP5
has also been shown to promote cap-
independent translation of cell survival
factors during mitosis in unstressed cells
(Liberman et al., 2009; Marash et al.,
2008). Its reported targets include
CDK1 and members of the Bcl familyof proteins. The involvement of DAP5 in processes aiding
apoptosis, and in cell survival during mitosis, renders it an inter-
esting target for therapy of aberrant cellular states characterized
by the dysregulation of apoptosis, such as cancer and autoim-
mune diseases.
The MIF4G domain of eIF4G and DAP5 is central to their
function because it provides a platform for the interaction with
eIF4A and eIF3, which are critical for translation initiation. The
MIF4G domain of eIF4G was reported to be sufficient to medi-
ate IRES-driven translation initiation (De Gregorio et al., 1998,
1999; Hundsdoerfer et al., 2005; Lomakin et al., 2000), suggest-
ing that the IRES binding determinants of DAP5 may also lie
within its MIF4G domain. Surprisingly, however, in spite of their
homology and shared functionality, eIF4G and DAP5 can act
upon different sets of IRES elements, as in the case of EMCV
(Nevins et al., 2003). The MIF4G domain of DAP5 share 39%
and 43%sequence identity with eIF4GI and eIF4GII, respectively
(Figure 1A). The crystal structure of the MIF4G domain from
human eIF4GII revealed a HEAT domain consisting of five pairs
of HEAT repeats of antiparallel a helices forming a crescent-
shaped right-handed solenoid (Marcotrigiano et al., 2001). Muta-
tional analyses mapped the sites of interaction with eIF4A and
potential contacts with IRES RNA to adjacent surfaces on the
molecule (Marcotrigiano et al., 2001). There is as yet no structural
Table 1. DiffractionDataCollection andRefinement Statistics for
DAP5M
Data Collection
X-ray source CHESS Beamline A1
Wavelength (A˚) 0.9785
Resolution (A˚) 30–2.3 (2.38–2.3)
Space group C2
Cell parameters (A˚, ) a = 167.630, b = 56.573, c = 74.339,
a = 90.00, b = 112.05, g = 90.00
Molecules per ASU 2
Mosaicity () 0.9
Unique reflections 28,017
Redundancy 13.2 (10.5)
I/s(I) 23.4 (4.8)
Completeness (%) 99.8 (87.5)
Rsym 0.107 (0.35)
Refinement
Rwork/Rfree 22.2/25.6
Number of atoms 4,038
Protein 3,837
Ligand/ion 25
Water 176
Rmsd
Bond lengths (A˚) 0.002
Bond angles () 0.620
Ramachandran, favored 99.1%
Ramachandran, outliers 0.2%
Rmsd, root-mean-square deviation.
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Crystal Structure of the DAP5 MIF4G Domaininformation onMIF4G’s binding to IRESs. The crystal structure of
the yeast eIF4G-eIF4A complex showed that the convex surface
of MIF4G makes contact with eIF4A at both its N-terminal and
C-terminal regions (Schu¨tz et al., 2008). As in human, yeast
also possesses two isoforms of eIF4G. The crystal structure
contains isoform I but is referred to as eIF4G throughout the
text for simplicity. This structure also revealed a third site of inter-
action: a conserved tryptophan residue (Trp 579 in yeast eIF4GI
also known as TIF4631; Trp 734 in human eIF4GI; Trp 733 in
human eIF4GII) at the N terminus of theMIF4G domain anchored
to the eIF4A C-terminal domain. Mutation of this residue in yeast
eIF4G weakens its interaction with eIF4A and results in the loss
of the ability to stimulate eIF4A ATPase activity in vitro and
a temperature-sensitive phenotype in vivo (Schu¨tz et al., 2008).
This tryptophan residue and most of the residues in the MIF4G
domain that make direct contact with eIF4A are conserved
in DAP5.
To elucidate the similarities and differences responsible for the
crucial functional interactions of the MIF4G domains of DAP5
and eIF4G, we solved the crystal structure of the DAP5 MIF4G
domain (hereafter referred to as DAP5M) (Frank et al., 2010).
DAP5M adopts the same overall fold as eIF4G but with signifi-
cant structural differences in some of the helices and their con-
necting loops that have potential implications for the distinct
IRES binding properties of the two proteins. Conserved residues
expected to interact with eIF4A are for the most part in the same
conformation as seen for the yeast eIF4G-eIF4A complex, and
the binding properties of the complex it forms with eIF4AI was
investigated by mutational analysis. Additionally, quantitative
analysis of the affinity of DAP5M to eIF4A indicates that it is
one order of magnitude weaker than that of eIF4GI to eIF4A,
which likely underlies DAP5’s weaker stimulation of the RNA
unwinding activity of eIF4A compared to eIF4GI.
RESULTS
Overall Structure of the DAP5 MIF4G Domain
Based on the crystal structure of the middle domain of eIF4GII,
we crystallized and determined the structure of a construct
encompassing the middle domain of DAP5 (DAP5M; residues
61 to 323) at 2.3 A˚ resolution using molecular replacement.
Subsequent model building, simulated annealing, energy mini-
mization, and individual B-factor refinement led to final Rfree
and R values of 25.6% and 22.2% (Table 1). DAP5M belongs
to the family of HEAT (Huntingtin, Elongation factor 3, PR65/A,
and TOR) domains, which are characterized by repeated pairs
of antiparallel a helices connected by turns/loops arranged
about a common axis (Figure 2A). Each pair of helices (labeled
a and b) constitutes one HEAT repeat, and in DAP5M, ten helices
form five HEAT repeats (labeled 1 to 5), which are stacked on top
of each other and stabilized by intervening hydrophobic interac-
tions. Small rotations between the packing of successive HEAT
repeats impart a twist to the overall structure, giving rise to
a right-handed superhelical axis perpendicular to the repeat
helical axes. The MIF4G domain can be subdivided into two
smaller subdomains because of the presence of a long 21-
residue loop connecting helices 2b and 3a. Thus, subdomain 1
encompasses HEAT repeats 1 and 2 and subdomain 2 includes
HEAT repeats 3 to 5. A tilt of 48 between these subdomainsStructure 21gives the molecule an overall crescent-shaped appearance
with two distinctly shaped surfaces, a concave surface and a
convex surface (Figure 2A).
The asymmetric unit of the crystal contains two independent
copies of DAP5M (chains A and B) related by a 2-fold noncrystal-
lographic symmetry axis (Figure S1 available online). Superposi-
tion of the two copies using the Dali server indicates a root-
mean-squared deviation (rmsd) of 1.0 A˚ for 223 corresponding
Ca atoms (Holm and Rosenstro¨m, 2010). The largest deviations
occur at the N terminus, where molecule A is longer by 12 resi-
dues in the electron density, and at the C terminus of helix 3a,
where the paths of the helices diverge considerably between
the two molecules. At approximately residue Val 182, helix 3a
of molecule B bends by a few degrees, leading into the connect-
ing loop to helix 3b. In molecule B, this connecting loop is well
ordered and modeled in the structure, whereas in molecule A it
is completely disordered. Molecule B is better defined in the
electron density with regard to the longer loops in the structure,
although the average overall backbone B-factors for both mole-
cules are comparable (molecule A: 42.9 A˚2; molecule B: 45.2 A˚2).
The two molecules bury a significant amount of surface area
(2,500 A˚2) at their interface; however, the residues in the inter-
face are for the most part polar in nature, and gel filtration anal-
ysis of DAP5M indicates a monomeric species in solution (data
not shown). Thus, the dimer observed here is likely an artifact
of crystallization and probably not physiologically relevant., 517–527, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 519
Figure 2. Structural Overview of DAP5M
(A) Ribbon representation of DAP5M. Each HEAT repeat is colored differently. Helix numbering is given on the right. In the left orientation, the concave surface of
the protein is indicated with a curved line and colored cylinders within the ribbons denote the superhelical axes. The right orientation, rotated by 30, highlights the
long loop between helices 2b and 3a (colored orange), which causes the molecule to be divided into two subdomains. See Figure S1.
(B) Structural superposition of DAP5M with the MIF4G domains of human eIF4GII (PDB ID code 1HU3) and S. cerevisiae eIF4G (TIF4631; PDB ID code 2VSO). All
molecular figures were generated using the program PyMol (The PyMOL Molecular Graphics System, v.1.2r3pre, Schro¨dinger).
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Crystal Structure of the DAP5 MIF4G DomainComparison of DAP5M and eIF4G MIF4G Domains
Two crystal structures of the MIF4G domain from eIF4G have
been determined previously: that from human eIF4GII and the
structure of the Saccharomyces cerevisiae eIF4Gmiddle domain
in complex with eIF4A (Marcotrigiano et al., 2001; Schu¨tz et al.,
2008). Human DAP5 shares 43% and 32% sequence identity
(based on structure-based sequence alignments) with human
eIF4GII and S. cerevisiae eIF4G, respectively, in their MIF4G
domains and all of them adopt the same overall fold (Figure 2B).
Superposition of DAP5M on human and yeast eIF4G using the
Dali server indicates rmsd values of 1.7 A˚ and 2.6 A˚, based on
190 and 212 corresponding Ca atoms, respectively (Holm and
Rosenstro¨m, 2010). However, there are significant differences
observed in the length and orientation of a number of helices.
Additionally, the loops connecting the helices differ considerably
in length and conformation. In particular, the concave side of the
molecule in the N-terminal region opposite the eIF4A binding site
encompassing the helices of HEAT repeats 1, 2, and 3 and the
loop connecting repeats 2 and 3 display very different conforma-
tions (Figure 2B). The loop connecting repeats 2 and 3 (residues
142 to 161) is 18 residues in length and extends outward from the
otherwise very compact structure of the HEAT domain. In the
eIF4GII structure, this loop is largely disordered and shorter by
six residues. Other notable differences occur in the loop con-
necting helices 3a and 3b (residues 185 to 200), which is well
ordered in DAP5 and disordered in eIF4GII, where it is longer
by 12 residues, and the loop connecting helices 4a and 4b (resi-
dues 236 to 249), which is longer in DAP5 by 7 residues. Large
structural differences such as these impart significant differ-
ences in shape and chemical attributes to their surfaces and
likely contribute to the functional differences observed between
these proteins, such as IRES binding.
Identification of a Potential IRES Binding Site in DAP5M
Although eIF4G and DAP5 have common protein binding part-
ners in eIF4A and eIF3, their interactions with nucleic acids are
distinct. In vitro studies of human eIF4GI have demonstrated520 Structure 21, 517–527, April 2, 2013 ª2013 Elsevier Ltd All rightsthat its MIF4G domain is able to interact with different RNAs,
namely, the EMCV IRES RNA and b-globin mRNA (Pestova
et al., 1996; Lomakin et al., 2000), and one study even reported
interactionwith DNA (Kim et al., 1999). TheDAP5MIF4Gdomain,
on the other hand, does not interact with the EMCV IRES RNA or
b-globin mRNA in vitro (Lomakin et al., 2000). Several studies
have suggested that DAP5 can initiate translation via IRES
elements found in a number of cellular mRNAs (Henis-Korenblit
et al., 2000, 2002; Hundsdoerfer et al., 2005; Lewis et al.,
2008; Nevins et al., 2003; Warnakulasuriyarachchi et al., 2004).
This raises the question as to whether DAP5M interacts with
these IRES elements in a manner similar to how eIF4G associ-
ates with the EMCV IRES for cap-independent translational
initiation.
To identify potential sites of IRES interaction, we show the
solvent-accessible surface of DAP5M colored according to its
electrostatic potential in Figure 3A. In the N-terminal region of
the molecule, there exists a large area of positively charged
surface, which could potentially interact with nucleic acid. Inter-
estingly, we found a sulfate ion from the crystallization buffer
bound to a cluster of positively charged residues (Lys 108, Lys
112, and Arg 165) in this region (Figure 3A). This interaction could
potentially mimic electrostatic interactions of the phospho-
diester backbone of IRES RNA with DAP5M. The positively
charged area corresponds to a highly conserved region among
various orthologs of DAP5 (Figures 3B and S2). Comparison of
the equivalent surface in human eIF4GII also reveals large
patches of positive potential but with significantly different distri-
bution of the charges, perhaps owing to the distinct IRES tar-
geted by these two proteins (Figure 3C).
The positively charged region in DAP5M is adjacent to the
eIF4A-binding site (see below), suggesting that IRES binding
may be coupled to the interaction with eIF4A. In support of
this, a previous analysis of the MIF4G domain from eIF4GII iden-
tified mutants that affect binding of both eIF4A and the EMCV
IRES (Marcotrigiano et al., 2001). Furthermore, the IRES interac-
tion is enhanced in the presence of eIF4A (Lomakin et al., 2000).reserved
Figure 3. Surface Properties of DAP5M and MIF4G Domain from eIF4GII
(A) Electrostatic potential surface representation of DAP5M. The surface was calculated using APBS (Baker et al., 2001): red <3kBT/e and blue >+3kBT/e, where
kB denotes Boltzmann constant and T denotes temperature. Inset: Enlargement of electrostatic surface surrounding the observed sulfate ion found onmolecule B
of DAP5M.
(B) Mapping of the surface conservation using selected eukaryotic DAP5 orthologs (see Figure S2).
(C) Electrostatic potential surface representation of the MIF4G domain from eIF4GII (PDB ID code 1HU3).
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Crystal Structure of the DAP5 MIF4G DomainThese observations indicate that there is cooperativity in binding
of eIF4A and RNA to eIF4G and that the sites of interaction are
probably in close proximity to one another. Considering the func-
tional and structural homology between eIF4G and DAP5, it is
likely that DAP5M utilizes a similar mode of cooperative binding
to eIF4A and IRES RNA. Based on our crystal structure of
DAP5M, it will be possible to carry out a mutational analysis of
the residues in this region to confirm its role in DAP5-mediated
IRES-driven translation initiation.
The Sites of Interaction with eIF4A Are Structurally
Conserved in theMiddleDomains of eIF4GandDAP5but
Have Different Binding Affinities
It was previously shown that DAP5M, like eIF4G, recruits eIF4A,
a member of the DEAD box RNA helicase family (Imataka et al.,
1997). eIF4A is a 46 kDa bilobal protein with its N- and C-terminal
domains connected by a flexible linker. Given the conservation
of the overall folds of the MIF4G domains of DAP5 and eIF4G,
it is likely that they interact with eIF4A in the same manner. To
analyze the potential site of eIF4A interaction on DAP5M, we
constructed a model of the complex by superposition of the
DAP5M structure onto the crystal structure of the S. cerevisiae
eIF4G-eIF4A complex (Schu¨tz et al., 2008) (Figure 4). As with
the yeast eIF4G-eIF4A complex, the DAP5M-eIF4A model
reveals that there are two main sites of interaction between the
two proteins. The C-terminal domain of eIF4A interacts with
the N-terminal region of DAP5M encompassing heat repeats 1
and 2 (Site 1), whereas the N-terminal domain of eIF4A makes
contact with the C-terminal part of DAP5M on helix 5b (Site 2).
Together, the two sites of interaction bury 2,100 A˚2 of surface
area at the interface. Additionally, a third site of interaction in
the yeast eIF4G-eIF4A complex was identified, which is contrib-
uted by a tryptophan residue connected to the MIF4G domainStructure 21through a flexible, N-terminal linker that buries it in the C-terminal
domain of eIF4A (Schu¨tz et al., 2008). This conserved tryptophan
residue, although present in DAP5 (Trp 50), could not be
modeled as it was not included in our crystallization construct
due to its likely flexible attachment. However, the contribution
of Trp 50 to the interaction of DAP5 with eIF4A in humans
is marginal, as observed in our binding and activity assays
in vitro (data not shown). This suggests that, unlike what is
observed in yeast, Trp 50 may not be as essential for DAP5’s
interaction with eIF4A or its effect may be more subtle in humans
and will require other assays to fully characterize its role.
Yeast eIF4GI middle domain and DAP5M have only 32% iden-
tity, yet the majority of eIF4A-interacting residues in eIF4G (19 of
24 total interface residues), as identified in the crystal structure of
the complex, are conserved in DAP5 (Figure 1B). Importantly, the
model of the DAP5M-eIF4A complex indicates that, in addition to
the sequence, the conformations of most of the residues at the
interface are also conserved, even in the absence of eIF4A. Of
the 24 residues that make contact at Site 1 and Site 2, approxi-
mately three-quarters are in very similar conformations (Figure 4).
This suggests that the binding mode between DAP5 and eIF4A
mirrors that of eIF4G and that the interaction occurs through,
for the most part, a preformed binding site on DAP5. Thus, we
expected the binding affinities of eIF4A for the MIF4G domains
of eIF4G and DAP5 to be comparable.
To ascertain whether this is indeed the case, we carried out
isothermal titration calorimetry (ITC) experiments to compare
dissociation constants for the interaction of human eIF4A (iso-
form I) with the MIF4G domains of human eIF4G (isoform I:
81% identical to eIF4GII in their MIF4G domains) and DAP5.
Both constructs included the conserved tryptophan residue
(Trp 50 in DAP5; Trp 734 in eIF4GI) as described in yeast. We
measured a dissociation constant of 0.136 mM for the binding, 517–527, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 521
Figure 4. Model of the DAP5M-eIF4A Complex
Center: Shown is the crystal structure of the yeast eIF4G-eIF4A complex (purple-gray) with DAP5M (red) superimposed on eIF4G. W579 (W50 in DAP5M), which
comprises the third interaction site in the eIF4G-eIF4A complex, is represented as orange sticks. Left: Detailed view of Site 1 interaction residues. Top: Residues
on the surface of eIF4G andDAPM that interact with eIF4A are shown as sticks. The view is rotated relative to the orientation in the center panel. Nitrogen, oxygen,
sulfur, and carbon atoms are colored blue, red, yellow, and pink (DAP5M)/light blue (eIF4G), respectively. Themajority of residues are conserved in sequence and
conformation. Labels for residue numbers are shown for DAP5M only. Bottom: Selected residues from the yeast eIF4G structure (light-blue carbon atoms) that
interact with yeast eIF4A (white carbon atoms) for which the corresponding residues in DAP5M were mutated. Labels for residue numbers from both yeast
eIF4G/eIF4A and human DAP5/eIF4AI are indicated. Right: Detailed view of Site 2 interaction residues with similar coloring and labeling scheme as above.
Structure
Crystal Structure of the DAP5 MIF4G Domainof eIF4A to eIF4Gwith a stoichiometry of 1:1 (Figure 5A). This is in
agreement with the crystal structure of the yeast eIF4G-eIF4A
complex and our gel filtration analysis (Figure S3), which both
show one molecule of eIF4A bound to a single MIF4G domain.
Surprisingly, we found that the affinity of DAP5M for eIF4A is
only 1.1 mM—about 10-fold lower than that of eIF4G, also with
a stoichiometry of 1:1 (Figure 5B). This suggests that despite
the conservation of the binding site in both sequence and struc-
ture, other residues outside of the binding site modulate the
affinity of MIF4G domains for eIF4A binding. Alternatively, it
may be possible that the few nonconserved residues in the inter-
face reduce the binding affinity or that the model of DAP5M-
eIF4A based on the yeast complex does not accurately reflect
the actual mode of binding altogether.
Mutational Analysis of Site 1 and Site 2 Residues in the
DAP5-eIF4A Complex
To examine whether residues predicted by the model of the
DAP5M-eIF4A complex are indeed important in the interaction,
we mutated conserved residues in DAP5M at the Site 1 and
Site 2 interfaces and carried out in vitro binding studies. At Site
1 we chose to mutate two key interactions: Asn 86 to alanine
(N86A) and Glu 125 to lysine (E125K). Asn 86 forms several
hydrogen bonds with backbone atoms from a loop in the
C-terminal lobe of eIF4A and Glu 125 makes a salt bridge with
Arg 312 of yeast eIF4A (Arg 324 in human eIFAI), also located522 Structure 21, 517–527, April 2, 2013 ª2013 Elsevier Ltd All rightson a loop in the C-terminal lobe (Figure 4, lower left panel). At
Site 2, Phe 296, which makes interactions with a hydrophobic
pocket on the N-terminal lobe of eIF4A, was mutated to alanine
(F296A) (Figure 4, lower right panel). These mutant proteins were
soluble as exhibited by their well-behaved gel filtration profiles
(Figure S3). Mutation of single residues at either the Site 1 or
Site 2 interfaces resulted in complete loss of binding in in vitro
pull-down assays (Figure 6A). The same results were obtained
using gel filtration chromatography (Figure S3). Our results agree
with those obtained by Morino et al. (2000), who showed that the
mutation of Phe 977 (equivalent to Phe 296 in DAP5) to Ala
(F977A) in eIF4GI resulted in loss of binding to eIF4A in cell
extracts. This confirms that DAP5M interacts with eIF4A in the
same manner as was observed for eIF4G, albeit with a lower
affinity, which may impact its ability to stimulate eIF4A activity.
Effect of DAP5M on the Helicase Activity
To assess the effect of the lower affinity DAP5M-eIF4A interac-
tion on helicase activity, we used a fluorescence-based activity
assay to monitor RNA unwinding by full-length human eIF4A
in vitro (O¨zesx et al., 2011). The stimulation of eIF4A helicase
activity through interaction with eIF4G is well established
in vitro using either protein purified from cell extracts or recombi-
nant protein, although the extent of stimulation depends on the
particular construct used (Abramson et al., 1988; Rogers et al.,
2001). Full-length eIF4G, however, is intrinsically unstable, andreserved
Figure 5. ITC Titration Binding Curves
(A) eIF4AI with eIF4GI(MIF4G) (residues 732–1003), where KD is the dissociation constant and N is the number of binding sites.
(B) eIF4AI with DAP5M (residues 48–323).
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approximately the C-terminal two-thirds of eIF4G, lacking
regions upstream of the MIF4G domain (residues 732–1571),
similar to one previously demonstrated to robustly stimulate
eIF4A ATPase activity in vitro (Korneeva et al., 2005). Analo-
gously for DAP5, we used a near full-length construct beginning
just N-terminal to the middle domain and extending to the
C terminus (residues 48–907). The reaction mix also includes
the accessory factor eIF4B, which enhances eIF4A processivity
(Rogers et al., 2001).
eIF4A and eIF4B display relatively low unwinding activity on
their own (Figure 7, green). Addition of wild-type DAP548–907 to
the reaction almost doubled the basal unwinding rate to 4.5%
per minute (Figure 7, red). The N86A mutant of DAP548–907,
which as demonstrated above abrogates binding of eIF4A
to DAP5M, returned the activity back to basal levels (Figure 7,
lavender), confirming the importance of DAP5-eIF4A binding
for stimulation of RNA unwinding activity. Thus, as with eIF4G,
DAP5 can stimulate eIF4A activity via interaction with its middle
domain. However, carrying out the unwinding reaction with
eIF4G732–1571 in our assay indicates that it is twice as potent as
DAP548–907 in stimulating helicase activity (Figure 7, blue). For
the above-mentioned experiments, all of the proteins in the
reaction mixtures were maintained at concentrations of 1 mM.
According to the dissociation constants determined above for
the middle domains, at 1 mM concentration DAP548–907 wouldStructure 21be less occupied by eIF4A than eIF4G732–1571, which would
be close to saturation, although the precise situation is more
complex because eIF4G732–1571 contains a second binding site
for eIF4A in its C-terminal region that is absent in DAP548–907.
Nonetheless, the 10-fold difference in binding affinity of eIF4A
with the middle domains of the two proteins likely contributes
to the observed differences in their respective stimulation of
unwinding activities. Indeed, increasing the DAP548–907 and
eIF4G732–1571 concentrations to 2 mM in the assay (Figure 7,
gray and gold) substantially reduces the observed difference in
unwinding activities between the two proteins.
DISCUSSION
We have determined the crystal structure of the MIF4G domain
from DAP5. Our structure reveals that the overall fold of
DAP5M is a helical HEAT domain that is very similar to that found
in crystal structures of the MIF4G domain from eIF4G. However,
significant conformational differences in the connecting loop
structures of DAP5M impart distinct shape and surface charac-
teristics to it. We also showed that DAP5M is functionally homol-
ogous to eIF4G in its ability to interact with and stimulate eIF4A
activity.
A precise molecular role for DAP5 is still lacking. The earliest
reports, via overexpression in vitro and in transfected cells,
ascribed an inhibitory role to DAP5 on both cap-dependent, 517–527, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 523
Figure 7. In Vitro Helicase Assay
The percent unwinding of the RNA substrate over time was monitored by
measuring the increase in fluorescence caused by eIF4A and eIF4B in the
absence (green) or in the presence of wild-typeDAP5 (red and gray) or its N86A
mutant (lavender), or in presence of the C-terminal two-thirds of eIF4G (blue
and gold). Each protein was present at 1 mM in the unwinding reaction unless
specified otherwise. The initial unwinding rates were extracted from the initial
linear portion of the unwinding time course and expressed as percent
unwinding per minute. Error bars represent the standard deviation of three
replicates. Wild-type DAP5 and its eIF4G equivalent stimulate the activity of
the helicase, whereas unwinding in the reaction containing DAP5 N86A is
comparable to that of eIF4A and eIF4B alone. There is an2-fold difference in
unwinding aided by DAP5 and eIF4G at 1 mM, but their eIF4A-stimulation
capacities are more similar at 2 mM.
Figure 6. In Vitro Pull-Down Experiments
Hexahistidine-tagged constructs of purified DAP5M and its mutants were
used as bait and purified eIF4AI as prey. Shown are Coomassie Brilliant Blue-
stained SDS-PAGE gels. Indicated on the left are protein marker sizes in kDa.
Pull-downs of eIF4Awith DAP5Mcontainmutations at Site 1 or Site 2. Lane 1 is
a control in which eIF4A alone is incubated with empty Ni-NTA beads to
account for nonspecific binding of eIF4A to the resin. Lane 2 is a positive
control with wild-type DAP5M, which shows strong binding to eIF4A. Lanes 3
to 5 are pull-downs with the indicated mutants of DAP5M, all three of which fail
to pull down eIF4A. See Figure S3.
Structure
Crystal Structure of the DAP5 MIF4G Domainand EMCV-IRES-driven translation. Based on this, it was postu-
lated that DAP5 could function as a general translation inhibitor
by sequestering eIF4A and eIF3, but not eIF4E, into inactive
complexes. Later studies often produced many conflicting
results with functions of DAP5 ranging from inhibitor of cap-
dependent translation (Henis-Korenblit et al., 2002), stimulator
of DAP5 IRES-dependent translation (Nevins et al., 2003), inert
in DAP5 IRES-dependent translation (Henis-Korenblit et al.,
2002), and even a stimulator of cap-dependent translation (Lee
and McCormick, 2006). All of these studies were based on over-
expression of DAP5 beyond physiological levels, which could
account for the varying results observed, depending on the
precise conditions and cell types used.
Much evidence now points to DAP5 being a scaffolding
protein in IRES-mediated translation. Knockout and knockdown
studies have established that DAP5 is an essential factor for the
translation of specific cellular mRNAs containing IRES elements
in their 50-UTRs, such as c-myc, CDK1 and Bcl family members,
and DAP5 itself (Yamanaka et al., 2000; Marash et al., 2008).
However, the molecular details of how DAP5 partakes in transla-
tion initiation and its relationship to eIF4G have remained elusive.
Our structure of DAP5M supports its role in IRES-mediated
translation in that it possesses a positive surface charge distribu-
tion distinct from that found in MIF4G and is well-suited for inter-
action with nucleic acids, although direct interaction between
DAP5M and IRES RNA remains to be demonstrated.
Our finding of a 10-fold affinity difference between eIF4A and
themiddle domains of eIF4G andDAP5 resulting in variable stim-
ulation eIF4A helicase activity further supports the notion that
DAP5 does not simply function as a general translational in-
hibitor. eI4FA is the most abundant initiation factor present in
the cell, present at concentrations of up to 30 mM, whereas
DAP5/eIF4G levels can be in the range of 2 to 6 mM (Duncan
and Hershey, 1983; Lee and McCormick, 2006). Thus, based
on the dissociation constants determined here, both DAP5 and
eIF4G would for the most part be in complex with eIF4A,
although DAP5 is likely more dynamic in this regard, owing to
its lower affinity for eIF4A. Indeed, the levels of DAP5 are signif-
icantly modulated under cellular stress conditions, particularly
during caspase activation, which causes a shift from cap-depen-524 Structure 21, 517–527, April 2, 2013 ª2013 Elsevier Ltd All rightsdent to cap-independent translation by the degradation of eIF4G
(Bushell et al., 2000; Svitkin et al., 1999; Henis-Korenblit et al.,
2000), thereby favoring the association of DAP5 with eIF4A.
Finally, the importance of the DAP5-eIF4A interaction was
further validated in recent translation rescue experiments from
rabbit reticulocyte lysate, where the ability of recombinant
DAP5 to rescue the translation of cellular IRESsdepended specif-
ically on the integrity of interactionbetween itsmiddledomain and
eIF4A (V.Gandin, personal communication). Futurestudiesaimed
at deciphering themolecular contribution of DAP5 to IRES-driven
translation will be required to unravel its true biological role.
EXPERIMENTAL PROCEDURES
Expression and Purification of Recombinant Proteins
TheMIF4G domain of human DAP5 (DAP5M; residues 48 to 323 and 61 to 323)
was subcloned into the BamHI and EcoRI restriction sites of the bacterialreserved
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Crystal Structure of the DAP5 MIF4G Domainexpression vector pProEx HTb (Invitrogen, Carlsbad, CA, USA). DAP5M
was expressed in Escherichia coli strain BL21 (Rosetta 2) by induction at
OD600 = 0.6 with 1 mM isopropyl-b-D-thiogalactoside (IPTG) for 4 hr at
30C. The protein was purified by nickel affinity chromatography on a Sephar-
ose 6 Fast Flow nickel affinity resin column (HisTrap FF, GE Healthcare, Little
Chalfont, UK). Following overnight TEV cleavage and dialysis against nickel
binding buffer, TEV protease (hexahistidine-tagged) was removed by applying
samples onto a HisTrap FF column and collecting the flowthrough. Tagged
and cleaved protein was further purified by gel filtration chromatography on
a HiLoad 16/60 Superdex 75 prep grade column (GE Healthcare) eluted with
a buffer containing 25 mM Tris (pH 8.0), 150 mM NaCl, 5% glycerol, 1 mM
phenylmethylsulfonyl fluoride (PMSF), and 1 mM dithiothreitol (DTT).
Human full-length eIF4AI was cloned into the BamHI and EcoRI restriction
sites of the bacterial expression vector pProEx Htb (Invitrogen). The protein
was expressed in E. coli strain BL21 (DE3) by autoinduction at OD600 = 0.6
overnight at 20C (Studier, 2005). The protein was purified by nickel affinity
chromatography and cleaved as described for DAP5M. The cleaved protein
was further purified by anion exchange chromatography on a Q Sepharose
Fast Flow resin column (HiTrap Q FF, GE Healthcare) before gel filtration, as
described for DAP5M.
The middle domain of human eIF4GI (MIF4G, residues 732 to 1003) was
cloned into pET-28b-SMT3 vector (Mossessova and Lima, 2000), in which
we mutated the EcoRI restriction site originally contained in the SUMO coding
region, enabling the use of EcoRI as forward restriction site together with
XhoI. A longer eIF4G construct encompassing its three HEAT-repeats domains
(732–1571) was cloned into the BamHI and NotI sites of the same vector. The
purification steps for MIF4G and eIF4G732-1571 are the same as for DAP5M
and eIF4A, respectively. Ulp-1 was used to desumoylate the fusion proteins
(Mossessova and Lima, 2000).
Human DAP5 (residues 48 to 907) was cloned into pProEx Htb (Invitrogen)
and expressed as an N-terminal hexahistidine fusion protein in E. coli strain
BL21 (Rosetta 2) by autoinduction overnight at 20C (Studier, 2005). The
protein was purified by nickel affinity chromatography on Ni-NTA Superflow
resin (QIAGEN, Hilden, Germany) followed by anion exchange chromatog-
raphy on a Q Sepharose Fast Flow resin column (HiTrap Q FF, GE Healthcare).
The protein was further purified by gel filtration chromatography on a Superdex
200 HR 10/300 column (GE Healthcare) eluted with a buffer containing 25 mM
Tris (pH 8.0), 150 mM NaCl, 5% glycerol, 1 mM phenylmethylsulfonyl fluoride
(PMSF), and 3 mM dithiothreitol (DTT).
All DNA sequences were confirmed by sequencing.
Mutagenesis of DAP5M
Mutants of DAP5M (48–323) and DAP5 were generated using the QuikChange
mutagenesis kit (Stratagene, La Jolla, CA, USA). Sequences of the mutants
were confirmed by plasmid DNA sequencing. The mutant proteins were ex-
pressed and purified as described above for the wild-type protein.
Crystallization and Data Collection
Tris(2-carboxyethyl)phosphine (TCEP; 1 mM final concentration) was added to
DAP5M (61–323) samples before use in crystallization trials. Crystals suitable
for structure determination were grown at 291 K using protein concentration of
15–20 mg/ml in drops of 2–4 ml volume (1–2 ml protein solution mixed with
1–2 ml reservoir solution). Crystals were grown in 0.1 M HEPES (pH 7.5),
0.2M ammonium sulfate, and 18%–20% (w/v) polyethylene glycol 5000mono-
methyl ether (PEG 5000 MME). Crystals were flash-cooled in a liquid-nitrogen
cryostream at 100 K, and data were collected in-house on a RigakuMicroMax-
007 HF microfocus X-ray generator fitted with Varimax X-ray optics and a
Saturn 944+ CCD detector.
Structure Determination
Crystallization, data collection, and initial structure solution of DAP5M were
carried out as described previously (Frank et al., 2010). In short, DAP5M
shares43% sequence identity with its homologous region in eIF4GII. Crystals
belong to thespacegroupC2with twomoleculesofDAP5Mperasymmetric unit
and diffracted to 2.4 A˚ (Table 1). Maximum likelihood molecular replacement
using the program Phaser (Read, 2001) and the structure of the eIF4GII MIF4G
domain (Protein Data Bank [PDB] ID code 1HU3; Marcotrigiano et al., 2001) re-
sulted in a solution with acceptable Z scores and log-likelihood gain (RFZ = 5.3;Structure 21TFZ = 11.3; LLG = 169). However, initial attempts at refinement did not reduce
the R factors. Therefore, we broke up the Phaser solution into 20 separate rigid
bodies, each corresponding to one helix and carried out rigid body refinement.
This reduced theR factors to47%,andsubsequent simulatedannealing, energy
minimization, and B-factor refinement with the program CNS (Bru¨nger et al.,
1998), as well as density modification, including the application of 2-fold NCS
symmetry averaging using the program DM (Cowtan and Main, 1993), further
reduced the R factors and resulted in reasonable electron density for majority
of the structure allowing us to build a model. During initial refinement against
the home source data set described before (Frank et al., 2010), CNS (Bru¨nger
et al., 1998) was used andNCS restraintswere applied. This refinement resulted
in a final model with an Rfree andR factor of 27.8%and 24.4%, respectively. The
resultingmodel was then further refined against a slightly higher resolution data
set (2.3 A˚) fromCHESS beamline A1 (Table 1) usingPhenix (Adams et al., 2002).
NCS restraints were removed for refinement using Phenix, but TLS refinement
was employed. The final model yielded an R factor of 22.2%andRfree of 25.6%.
Gel Filtration Chromatography
Half milliliter samples containing 0.5mgHis-DAP5M (orMIF4G, or eIF4A alone)
with or without 0.5 mg eIF4A were injected over a Superdex 200 10/300 GL
column (GE Healthcare) eluted with a buffer containing 25 mM Tris (pH 8.0),
150 mM NaCl, and 5% glycerol.
In Vitro Pull-Down Assays
Thirty micrograms of His-DAP5Mwere incubated in binding buffer (25 mM Tris
[pH 8.0], 150 mM NaCl, 60 mM imidazole [pH 8.0], and 5% glycerol) together
with 25 ml Ni-NTA Superflow resin (QIAGEN) and 100 mg of eIF4AI (3-fold
molar excess) for 30 min on ice in 100 ml reaction volume. After washing with
3 3 700 ml of binding buffer, proteins were eluted with 50 ml of elution buffer
(25 mM Tris [pH 8.0], 500 mM NaCl, and 500 mM imidazole [pH 8.0]). SDS-
PAGE was carried out on a 12% polyacrylamide gel and eluted proteins
were visualized with Coomassie Brilliant Blue staining.
Isothermal Titration Calorimetry
Experiments were performed with a VP-ITC instrument (MicroCal, GE Health-
care) at 20C. His-DAP5M (or desumoylated MIF4G from eIF4GI) and eIF4AI
samples were first dialyzed against a buffer containing 25 mM Tris (pH 8.0),
150 mM NaCl, and 1 mM DTT and then diluted to 0.5–1.0 mM and
0.05–0.1 mM, respectively. MIF4G domain proteins were loaded into the
syringe, whereas eIF4AI was loaded into the calorimetric cell. The heat of
binding was measured over the injection of 37 ml of MIF4G in 2 ml increments
into the cell. Data were fitted to a one binding site model using the Origin soft-
ware package (MicroCal, GE Healthcare).
Helicase Assays
Experiments were performed as described by O¨zesx et al. (2011). eIF4A, eIF4B,
DAP5, and eIF4Gwere used at a concentration of 1 mMunless specified other-
wise. The substrate is a double-reporter RNA construct with a 20 nt 50
overhang and a 24 bp duplex region. It was used at a concentration of
50 nM. Sequences are as follows, with underlined regions corresponding to
the duplex regions: template: 50-GAACAACAACAACAACAACAGAAAAAA
UUAAAAAAUUAAAAAACUCGGAGGGGCCGGUGGGGCC – 30; Cy3 strand
sequence: 50-Cy3- GUUUUUUAAUUUUUUAAUUUUUUC – 30; BHQ strand
sequence: 50- GGCCCCACCGGCCCCUCCG – BHQ – 30; 24-nt DNA com-
petitor: 50- GAAAAAATTAAAAAATTAAAAAAC – 30.
BHQ and Cy3-labeled RNA oligonucleotides were annealed side-by-side
(one nucleotide apart) to the template RNA. Competitor DNA was present in
10x excess to capture Cy3 RNA upon unwinding.
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